BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Transitions in Care in DMD Patient #3 - No Transition Plan

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Tuesday, December 1, 2020
Sponsor Information: 

Supported in part by a medical education grant from PTC Therapeutics, Inc.

Faculty

Meghan Harper-Shankie, MD
Pediatric Neurologist, Multidisciplinary MDA Neuromuscular Clinic, Beaumont Neuroscience Center
Transitions in Care in DMD Patient #3 - No Transition Plan
Activity Overview: 

This case study will explore transitions in care in DMD in patient #3 (23-year-old male). The focus of this case study is on no transition plan.

Learning Objectives: 
  • Best practices leading up to official transition of care to adult providers
  • Medical considerations in the management of DMD during transition (e.g., pulmonary and cardiac comorbidities, maintenance of steroid treatment).
  • Fostering independence during clinic visits
  • The importance of psychosocial intervention and facilitating patient engagement opportunities
  • Financial considerations that may impact access to care